Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew K. Balo currently holds 4,692 shares of DEXCOM INC (DXCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew K. Balo has been a net seller of DXCM stock. They have purchased $10.7K and sold $69.8M worth of shares.
Andrew K. Balo's most recent insider trade was on Oct 3, 2025, when they sold 1,285 shares at $0.00 per share.
Andrew K. Balo serves as Executive at DEXCOM INC (DXCM). They have executed 292 insider transactions totaling $69.8M over their tenure at the company.
Andrew K. Balo holds the position of Executive at DEXCOM INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Andrew K. Balo has shown a selling trading pattern, with $10.7K in total purchases and $69.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew K. Balo was on Sep 15, 2020, when they sold $2.1M worth of DXCM shares. This transaction involved 5,256 shares at $397.35 per share.
Andrew K. Balo currently owns 4,692 shares of DEXCOM INC (DXCM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew K. Balo's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew K. Balo has 292 Form 4 filings on record as an insider at DEXCOM INC.
Set alerts for Andrew K. Balo and 40,000+ other insiders.